Retraction
LncRNA FOXD3-AS1 Promotes Tumorigenesis of Glioma via Targeting miR-128-3p/SZRD1 Axis
Paper Information
Record ID:
35093
Author(s):
Publication Date:
December 07, 2021
Retraction Date:
January 20, 2022
(3.8 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations3
Post-Retraction(75.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
1
After 2+ years
854
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Role of glioma stem cells in promoting tumor chemo- and radioresistance: A systematic review of potential targeted treatments
Edoardo Agosti, Marco Zeppieri, Mattia Ghidoni et al. (7 authors)
World Journal of Stem Cells
Open Access
Published: May 2024
5 citations
5 citations
854 days after retraction
Prognostic value and immune-infiltration pattern of FOXD3-AS1 in patients with glioma
Zhenhua Chen, Yi Zhang, Sujuan Feng et al. (8 authors)
Frontiers in Pharmacology
Open Access
Published: Apr 2023
4 citations
4 citations
439 days after retraction
Succinylation-Associated LncRNA Signature as the Prognosis of Colon Cancer Identified by an Integrative Bioinformatics Analysis
Siming Zhang, Cheng Shen, Jue Gu et al. (7 authors)
Research Square (Research Square)
Open Access
Published: Jul 2022
183 days after retraction
Quick Stats
Total Citations:
5
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025